MIRM - Mirum Pharmaceuticals, Inc.
93.04
5.240 5.632%
Share volume: 777,401
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$87.80
5.24
0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-12-2024 | 02-26-2025 | 05-07-2025 | 08-06-2025 | 11-04-2025 | 02-25-2026 | |
| Assets | |||||||||
| Total Assets | 651.962 M | 660.754 M | 667.893 M | 670.754 M | 690.245 M | 725.825 M | 785.115 M | 842.813 M | |
| Current Assets | 389.465 M | 367.829 M | 386.626 M | 392.788 M | 410.818 M | 453.398 M | 530.575 M | 549.684 M | |
| Inventories | 21.606 M | 20.438 M | 21.594 M | 22.403 M | 22.418 M | 22.941 M | 24.021 M | 24.887 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 45.126 M | 61.476 M | 57.812 M | 65.852 M | 76.430 M | 93.527 M | 86.644 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 302.843 M | 233.245 M | 222.969 M | 222.503 M | 211.822 M | 228.122 M | 282.021 M | 296.683 M | |
| Total Non-current Assets | 0.000 | 17.075 M | 9.321 M | 12.526 M | 20.912 M | 17.112 M | 2.470 M | 8.105 M | |
| Property Plant Equipment | 501.000 K | 1.101 M | 1.212 M | 1.139 M | 1.108 M | 1.177 M | 1.277 M | 1.862 M | |
| Other Assets | 261.996 M | 291.574 M | 279.630 M | 276.402 M | 277.894 M | 270.770 M | 252.783 M | 289.785 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 651.962 M | 660.754 M | 667.893 M | 670.754 M | 690.245 M | 725.825 M | 785.115 M | 842.813 M | |
| Total liabilities | 417.359 M | 431.766 M | 435.869 M | 445.114 M | 456.989 M | 470.667 M | 493.069 M | 528.123 M | |
| Total current liabilities | 105.909 M | 112.308 M | 115.751 M | 126.551 M | 127.577 M | 144.796 M | 160.359 M | 205.799 M | |
| Accounts Payable | 15.983 M | 9.842 M | 9.545 M | 14.618 M | 11.639 M | 17.657 M | 12.167 M | 9.614 M | |
| Other liabilities | 4.615 M | 12.216 M | 12.452 M | 10.481 M | 20.903 M | 16.938 M | 23.342 M | 12.527 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 306.835 M | 307.242 M | 307.666 M | 308.082 M | 308.509 M | 308.933 M | 309.368 M | 309.797 M | |
| Other liabilities | 4.615 M | 12.216 M | 12.452 M | 10.481 M | 20.903 M | 16.938 M | 23.342 M | 12.527 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 234.603 M | 228.988 M | 232.024 M | 225.640 M | 233.256 M | 255.158 M | 292.046 M | 314.690 M | |
| Common stock | 816.134 M | 835.621 M | 851.495 M | 870.194 M | 892.372 M | 919.525 M | 953.823 M | 981.883 M | |
| Retained earnings | -581.518 M | -606.156 M | -620.391 M | -644.181 M | -658.858 M | -664.719 M | -661.814 M | -667.544 M |